Literature DB >> 15710731

Impact of combination evidence based medical treatment in patients with acute coronary syndromes in various TIMI risk groups.

D Mukherjee, J Fang, E Kline-Rogers, R Otten, K A Eagle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15710731      PMCID： PMC1768770          DOI： 10.1136/hrt.2004.036459

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

1.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

2.  Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2).

Authors:  Debabrata Mukherjee; Prasanth Lingam; Stanley Chetcuti; P Michael Grossman; Mauro Moscucci; Ann E Luciano; Kim A Eagle
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

3.  Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes.

Authors:  Debabrata Mukherjee; Jianming Fang; Stanley Chetcuti; Mauro Moscucci; Eva Kline-Rogers; Kim A Eagle
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

4.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28
  4 in total
  3 in total

Review 1.  Polypill: an affordable strategy for cardiovascular disease prevention in low-medium-income countries.

Authors:  Patricio López-Jaramillo; Silvia González-Gómez; Diego Zarate-Bernal; Andrés Serrano; Leonor Atuesta; Christian Clausen; Claudia Castro-Valencia; Paul Camacho-Lopez; Johanna Otero
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-03-16

2.  Optimal combination secondary prevention drug treatment and stroke outcomes.

Authors:  Jong-Ho Park; Bruce Ovbiagele
Journal:  Neurology       Date:  2014-11-19       Impact factor: 9.910

3.  Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Authors:  Tianyu Li; Xiaofang Tang; Ying Song; Yi Yao; Xueyan Zhao; Zhan Gao; Yuejin Yang; Runlin Gao; Bo Xu; Jinqing Yuan
Journal:  Glob Heart       Date:  2021-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.